Honors Ligand Named Biopharma Deal of the Year WinnerLigand Pharmaceuticals acquired Pfenex in an urgent year for Covid treatments.May 05, 2021
Healthcare Pfizer Acquires Amplyx PharmaceuticalsAmplyx develops therapies for debilitating and life-threatening diseases that affect the immunocompromised.April 29, 2021
Private Equity WindRose Health Recapitalizes VeristatVeristat's position in biostatistics and complex clinical trials was a major factor in WindRose's decision.April 07, 2021
Private Equity Avista Capital Makes Investment in eMoleculesAvista expects the purchase will help expedite its clients' drug discovery programs.March 25, 2021
SPACs 4D Pharma Merges With Longevity SPAC4D Pharma is one of an increasingly large number of companies utilizing SPACs to trade publicly.March 22, 2021
Private Equity CVC Capital is Reportedly Near a $2.6B Deal for Pharma Firm CooperThe private equity firm is negotiating detailed terms of an agreement with Cooper’s owner, Charterhouse.March 09, 2021
Healthcare Roivant Purchases Silicon TherapeuticsRoivant expects integrating Silicon's platform will expand its drug discovery services.February 27, 2021
Manufacturing W.R. Grace Backs Fine Chemistry BusinessFCS adds a portfolio of high-value products and services to Grace’s existing pharma portfolio.February 26, 2021
Manufacturing PMC Group Backs Copperhead ChemicalPMC expects the acquisition will strengthen its inroads to the pharmaceutial marketFebruary 23, 2021
